Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #44141 on OncoSec Medical Inc (ONCSQ)
Country Squire
04/14/18 5:05 AM
#44142 RE: chickpea598 #44141
trading.jeff
04/14/18 11:23 AM
#44145 RE: chickpea598 #44141
"At the time of abstract submission, 5 patients have completed all study-related procedures ... Two patients with treatment refractory TNBC received nivolumab ... and experienced clinically meaningful objective responses. Updated data will be presented."